Canada-based eMurmur has been granted US Food and Drug Administration approval for its cloud and mobile-based AI platform that detects heart murmurs. A recording from a third-party digital stethoscope is uploaded via eMurmur's app to a HIPAA-compliant server, where it is analysed against a database of sounds and cardiologist notes. The company says the technology can detect atrial fibrillation, which occurs when blood flow in one part of the body slows down while another part speeds up.
Canada-based eMurmur has been granted US Food and Drug Administration approval for its cloud and mobile-based AI platform that detects heart murmurs. A recording from a third-party digital stethoscope is uploaded via eMurmur's app to a HIPAA-compliant server, where it is analysed against a database of sounds and cardiologist notes. The company said its app has a success rate of between 85% and 90%, compared with traditional levels of 25% to 30%, and it is using educational programmes to encourage widespread adoption.